|
JAMA Oncology |
A Case of Gastric Thickening and a Large Ovarian Mass |
1 |
Yes |
6/27/2027 |
|
JAMA Oncology |
A Case of Multiple Hemorrhagic Friable Nodules |
1 |
Yes |
1/5/2026 |
|
JAMA Oncology |
A Young Man With a Neck Mass and Hypereosinophilia |
1 |
Yes |
10/19/2026 |
|
JAMA Oncology |
Advancing Global Pharmacoequity in Oncology |
1 |
Yes |
11/14/2027 |
|
JAMA Oncology |
Aiming at a Tailored Cure for ERBB2-Positive Metastatic Breast CancerA Review |
1 |
Yes |
4/21/2025 |
|
JAMA Oncology |
Aiming at a Tailored Cure for ERBB2-Positive Metastatic Breast Cancer |
1 |
Yes |
4/21/2025 |
|
JAMA Oncology |
American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non Small Cell Lung Cancer |
1 |
Yes |
4/11/2027 |
|
JAMA Oncology |
An Anal Lesion in a 27-Year-Old Patient |
1 |
Yes |
8/22/2027 |
|
JAMA Oncology |
An Atypical Rash on the Chest |
1 |
Yes |
12/29/2025 |
|
JAMA Oncology |
Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic |
1 |
Yes |
11/7/2025 |
|
JAMA Oncology |
Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic |
1 |
Yes |
11/7/2025 |
|
JAMA Oncology |
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19 |
1 |
Yes |
8/16/2025 |
|
JAMA Oncology |
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19 |
1 |
Yes |
8/16/2025 |
|
JAMA Oncology |
Asymptomatic Cutaneous Plaques on the Scalp and Face in an Older Adult Woman |
1 |
Yes |
7/21/2025 |
|
JAMA Oncology |
Asymptomatic Cutaneous Plaques on the Scalp and Face in an Older Adult Woman |
1 |
Yes |
7/21/2025 |
|
JAMA Oncology |
Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs |
1 |
Yes |
10/3/2027 |
|
JAMA Oncology |
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients - A Review |
1 |
Yes |
7/25/2027 |
|
JAMA Oncology |
Circulating Tumor HPV DNA for Surveillance of HPV-Positive Oropharyngeal Squamous Cell Carcinoma - A Narrative Review |
1 |
Yes |
10/12/2026 |
|
JAMA Oncology |
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB) |
1 |
Yes |
4/21/2025 |
|
JAMA Oncology |
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB) - A Systematic Review and Delphi Consensus Statement |
1 |
Yes |
4/21/2025 |
